To determine whether changes in SMN after 3-MA treatment can be detected in isolated MNs from an in vivo SMA model, we used the Smn−/−;SMN2+/+ (mutSMA) mouse. The gene discussed is SMN1; the disease is proximal spinal muscular atrophy.